Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
COSCIENS Biopharma Inc. (CSCI) had Receiveable Turnover of 0.81 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$1.50M |
|
$-3.65M |
|
$1.06M |
|
$0.44M |
|
$5.12M |
|
$-3.62M |
|
$-0.04M |
|
$-3.65M |
|
$-3.65M |
|
$-3.65M |
|
$-3.65M |
|
$-3.65M |
|
$-3.65M |
|
$-3.62M |
|
$-3.32M |
|
3.15M |
|
3.15M |
|
$-1.16 |
|
$-1.16 |
|
| Balance Sheet Financials | |
$20.35M |
|
$10.66M |
|
$10.79M |
|
$31.14M |
|
$7.06M |
|
-- |
|
$13.94M |
|
$21.00M |
|
$10.14M |
|
$10.14M |
|
$10.14M |
|
3.15M |
|
| Cash Flow Statement Financials | |
$-1.88M |
|
$-0.61M |
|
$-0.20M |
|
$16.39M |
|
$13.76M |
|
$-2.63M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
29.53% |
|
-241.13% |
|
-241.13% |
|
-- |
|
-243.67% |
|
-243.67% |
|
$-2.49M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.43 |
|
|
Receiveable Turnover |
0.81 |
111.54 |
|
-36.03% |
|
-36.03% |
|
-11.74% |
|
-36.03% |
|
$3.22 |
|
$-0.79 |
|
$-0.60 |
|